Effect of the Active Cycle of Breathing Technique on Coronary Artery Bypass Graft Patients' Outcomes

NCT ID: NCT06910020

Last Updated: 2025-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-10

Study Completion Date

2025-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Following CABG surgery, patients are at risk for several complications. One of the most common complications is postoperative pulmonary complications, which include atelectasis and dyspnea. These complications cause prolonged ICU length of stay and increased health care costs. Several studies recommended the active cycle of breathing technique as a method that increases secretion removal and improves lung functions, thus reducing the incidence of postoperative pulmonary complications. Our study aims to investigate the effect of the active cycle of breathing technique on coronary artery bypass graft patients' outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Bypass Coronary Arterial Disease (CAD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Cycle of Breathing Technique

Patients who will perform ACBT exercises in addition to the routine ICU care.

Group Type EXPERIMENTAL

Active Cycle of Breathing Technique

Intervention Type OTHER

* Patients will assume the sitting position and relax their shoulders, then perform the following:

1. Breathing control (abdominal breathing)
2. Chest expansion (thoracic breathing)
3. Huff cough (forced expiratory technique)
* After completing the above actions, patients will be asked to cough up the residual deep sputum to promote pulmonary expansion.
* The ACBT intervention will be performed for three days, each day two sessions, each session three courses, with 10 minutes of rest between them as needed.

Control Group

Patients who will receive routine ICU care (chest physiotherapy and incentive spirometer) without ACBT.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active Cycle of Breathing Technique

* Patients will assume the sitting position and relax their shoulders, then perform the following:

1. Breathing control (abdominal breathing)
2. Chest expansion (thoracic breathing)
3. Huff cough (forced expiratory technique)
* After completing the above actions, patients will be asked to cough up the residual deep sputum to promote pulmonary expansion.
* The ACBT intervention will be performed for three days, each day two sessions, each session three courses, with 10 minutes of rest between them as needed.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any adult patient who will undergo CABG

Exclusion Criteria

* Mechanically ventilated patients on the first postoperative day.
* Patients with preoperative lung collapse or pleural effusion.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shaimaa Nagi Abdelkader Yousef

Demonstrator of Critical Care and Emergency Nursing

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiothoracic and Vascular Surgery Center

Al Mansurah, Dakahliya, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

320

Identifier Type: REGISTRY

Identifier Source: secondary_id

320

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.